MNPR vs AAPL: Which Stock is Better?
Side-by-side comparison of Monopar Therapeutics and Apple Inc in 2026
MNPR
Monopar Therapeutics
$70.32
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | MNPR | AAPL | Winner |
|---|---|---|---|
| Market Cap | $469.92M | $3.66T | AAPL |
| P/E Ratio | N/A | 33.85 | AAPL |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.0% | 6.4% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze MNPR
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MNPR or AAPL a better investment?
Comparing MNPR and AAPL: Monopar Therapeutics has a market cap of $469.92M while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MNPR and AAPL?
MNPR (Monopar Therapeutics) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MNPR or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MNPR or AAPL?
AAPL has higher revenue growth at 6.4% vs 0.0% for MNPR.
Which company is more profitable: MNPR or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for MNPR.
Which is the larger company: MNPR or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $469.92M for MNPR.
Should I buy MNPR or AAPL in 2026?
Both MNPR and AAPL have investment merit. MNPR trades at $70.32 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MNPR and AAPL stock?
Key differences: Market Cap ($469.92M vs $3.66T), P/E Ratio (N/A vs 33.8x), Revenue Growth (0.0% vs 6.4%), Gross Margin (0.0% vs 46.9%).